Company:  ULTRAGENYX PHARMACEUTICAL ... (RARE)
Form Type:  4
Filing Date:  11/8/2018 
CIK:  0001515673 
Address:  60 LEVERONI COURT 
City, State, Zip:  NOVATO, California 94949 
Telephone:  415-483-8800 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$69.04  
Change: 
0.99 (1.46%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$3.94B
Trade RARE now with 

© 2019  
Description of Business
We are a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. We target diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no currently approved therapies. The patients we seek to treat have diseases with limited or no treatment options, and we recognize that their lives and well-being are dependent upon our efforts to develop new therapies. For this reason, we are passionate about developing these therapies with the utmost urgency and care. We were founded in April 2010 by our current President and Chief Executive Officer, Emil Kakkis, M.D., Ph.D., and we have since assembled an experienced team with extensive rare disease drug development and commercialization capabilities.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES